Dr Tahani I Hamideh, OD in Laurel, MD - Medicare Optometrist Provider

Dr Tahani I Hamideh, OD is a medicare enrolled "Optometrist" provider in Laurel, Maryland. Her current practice location is 14726 Baltimore Ave, 14728, Laurel, Maryland. You can reach out to her office (for appointments etc.) via phone at (301) 776-0075.

Dr Tahani I Hamideh is licensed to practice in Maryland (license number TA 1951) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1477683258.

Contact Information

	Dr Tahani I Hamideh, OD
	14726 Baltimore Ave, 14728, Laurel, MD 20707-4816
	(301) 776-0075
	(301) 604-9490

Healthcare Provider's Profile

Full Name	Dr Tahani I Hamideh
Gender	Female
Speciality	Optometrist
Location	14726 Baltimore Ave, Laurel, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1477683258
Provider Enumeration Date: 03/07/2007
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 9739344417
Enrollment ID: I20120702000232

Medical Identifiers

Medical identifiers for Dr Tahani I Hamideh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477683258	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	TA 1951 (Maryland)	Primary
152W00000X	Optometrist	0618001493 (Virginia)	Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Tahani I Hamideh allows following entities to bill medicare on her behalf.

Provider Name	Baltimore Eye Physicians, Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1508911660 PECOS PAC ID: 9739145095 Enrollment ID: O20041208000407

News Archive

Research describes novel molecules designed to treat or prevent COVID-19 infection

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.

Benefits and harms of screening infants for hyperbilirubinemia still unclear

According to a new recommendation from the U.S. Preventive Services Task Force, there is insufficient evidence to assess the balance of benefits and harms of screening infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy. Hyperbilirubinemia is a condition marked by a high level of bilirubin in the blood, which is often apparent as yellow-colored skin and eyes (jaundice).

Two types of blood pressure drugs provide equal benefits, but side effects differ

People who are just beginning treatment for high blood pressure can benefit equally from two different classes of medicine - angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) - yet ARBs may be less likely to cause medication side effects, according to an analysis of real-world data published today in Hypertension, an American Heart Association journal.

EDAP's gross profit reduces 5.1% in 2010 second quarter

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today financial results for the second quarter ended June 30, 2010. The Company outlines strategic initiatives to counter the continuing weak global economic climate.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tahani I Hamideh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Tahani I Hamideh, OD 5211 Daybrook Cir Apt 240, Baltimore, MD 21237-5051 Ph: (410) 258-3622	Dr Tahani I Hamideh, OD 14726 Baltimore Ave, 14728, Laurel, MD 20707-4816 Ph: (301) 776-0075

News Archive

Research describes novel molecules designed to treat or prevent COVID-19 infection

Benefits and harms of screening infants for hyperbilirubinemia still unclear

Two types of blood pressure drugs provide equal benefits, but side effects differ

EDAP's gross profit reduces 5.1% in 2010 second quarter

Optometrist in Laurel, MD

Dr. Ronald Geoffrey Havelock, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3450 Fort Meade Rd, Laurel Professional Bld. Ste 104, Laurel, MD 20724 Phone: 301-483-3323 Fax: 301-483-3345
Dr. Larry Allan Rubin, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 14700 Baltimore Ave, Laurel, MD 20707 Phone: 301-245-3903 Fax: 301-371-3983
Dr. Victoria Harmony Grinstead, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 14811 Baltimore Ave, Laurel, MD 20707 Phone: 301-490-6030
Dr. Richard T Li, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 14700 Baltimore Ave, Laurel, MD 20707 Phone: 301-245-3903 Fax: 301-371-3983
Dr Claudia L Blemard Optometrist Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3549 Russett Grn E, Laurel, MD 20724 Phone: 301-604-1593
20/20 Retail Management, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15100 Baltimore Ave, Laurel, MD 20707 Phone: 301-985-2585

Dr Tahani I Hamideh, OD - Medicare Optometrist in Laurel, MD

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Research describes novel molecules designed to treat or prevent COVID-19 infection

Benefits and harms of screening infants for hyperbilirubinemia still unclear

Two types of blood pressure drugs provide equal benefits, but side effects differ

EDAP's gross profit reduces 5.1% in 2010 second quarter

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Research describes novel molecules designed to treat or prevent COVID-19 infection

Benefits and harms of screening infants for hyperbilirubinemia still unclear

Two types of blood pressure drugs provide equal benefits, but side effects differ

EDAP's gross profit reduces 5.1% in 2010 second quarter

Optometrist in Laurel, MD